Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,830 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
Nappi RE, Paoletti AM, Volpe A, Chiovato L, Howard B, Weiss H, Ricciotti N. Nappi RE, et al. Among authors: howard b. Eur J Contracept Reprod Health Care. 2014 Aug;19(4):285-94. doi: 10.3109/13625187.2014.918596. Epub 2014 Jun 13. Eur J Contracept Reprod Health Care. 2014. PMID: 24923685 Free PMC article. Clinical Trial.
A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Kroll R, Seidman L, Ricciotti N, Howard B, Weiss H. Kroll R, et al. Among authors: howard b. Eur J Contracept Reprod Health Care. 2015;20(4):249-58. doi: 10.3109/13625187.2014.979282. Epub 2014 Dec 19. Eur J Contracept Reprod Health Care. 2015. PMID: 25522805 Clinical Trial.
Differences in reporting Pearl Indices in the United States and Europe: Focus on a 91-day extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Lobo Abascal P, Luzar-Stiffler V, Giljanovic S, Howard B, Weiss H, Trussell J. Lobo Abascal P, et al. Among authors: howard b. Eur J Contracept Reprod Health Care. 2016;21(1):88-91. doi: 10.3109/13625187.2015.1059416. Epub 2015 Jun 26. Eur J Contracept Reprod Health Care. 2016. PMID: 26115381 Free PMC article.
Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study.
Thomas MA, Morlock R, Dart C, Howard B. Thomas MA, et al. Among authors: howard b. J Sex Med. 2022 Jun;19(6):975-982. doi: 10.1016/j.jsxm.2022.03.221. Epub 2022 Apr 10. J Sex Med. 2022. PMID: 35418329 Clinical Trial.
CONCLUSION: As a non-hormonal, woman-controlled, on-demand, lubricating contraceptive gel, VPM offers women a unique set of benefits with positive impacts on their sexual health. Thomas MA, Morlock R, Dart C, Howard B. Sexual Satisfaction Results With the Vaginal pH …
CONCLUSION: As a non-hormonal, woman-controlled, on-demand, lubricating contraceptive gel, VPM offers women a unique set of benefits with po …
EVO100 prevents chlamydia and gonorrhea in women at high risk of infection.
Chappell BT, Mena LA, Maximos B, Mollan S, Culwell K, Howard B. Chappell BT, et al. Among authors: howard b. Am J Obstet Gynecol. 2021 Aug;225(2):162.e1-162.e14. doi: 10.1016/j.ajog.2021.03.005. Epub 2021 Mar 8. Am J Obstet Gynecol. 2021. PMID: 33705748 Clinical Trial.
1,830 results